ZA844023B - Liquid prolonged release pharmaceutical formulations containing ionic constituents - Google Patents

Liquid prolonged release pharmaceutical formulations containing ionic constituents

Info

Publication number
ZA844023B
ZA844023B ZA844023A ZA844023A ZA844023B ZA 844023 B ZA844023 B ZA 844023B ZA 844023 A ZA844023 A ZA 844023A ZA 844023 A ZA844023 A ZA 844023A ZA 844023 B ZA844023 B ZA 844023B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulations
formulations containing
release pharmaceutical
prolonged release
containing ionic
Prior art date
Application number
ZA844023A
Other languages
English (en)
Inventor
Jerry L Sheumaker
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of ZA844023B publication Critical patent/ZA844023B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA844023A 1983-09-16 1984-05-28 Liquid prolonged release pharmaceutical formulations containing ionic constituents ZA844023B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53286483A 1983-09-16 1983-09-16

Publications (1)

Publication Number Publication Date
ZA844023B true ZA844023B (en) 1985-03-27

Family

ID=24123487

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA844023A ZA844023B (en) 1983-09-16 1984-05-28 Liquid prolonged release pharmaceutical formulations containing ionic constituents

Country Status (16)

Country Link
EP (1) EP0139881B1 (ja)
JP (1) JPH0688901B2 (ja)
KR (1) KR910003557B1 (ja)
AT (1) ATE42894T1 (ja)
AU (1) AU565487B2 (ja)
CA (1) CA1221632A (ja)
DE (1) DE3478085D1 (ja)
DK (1) DK164019C (ja)
FI (1) FI843609L (ja)
IE (1) IE57445B1 (ja)
IL (1) IL71886A (ja)
MX (1) MX171030B (ja)
NO (1) NO843673L (ja)
NZ (1) NZ208155A (ja)
PH (1) PH20237A (ja)
ZA (1) ZA844023B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
CA1331563C (en) * 1987-08-03 1994-08-23 Gaylen M. Zentner Device for the controlled release of drugs with donnan-like modulation by charged insoluble resins
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
US5186930A (en) * 1988-11-14 1993-02-16 Schering Corporation Sustained release oral suspensions
SE9103110D0 (sv) 1991-10-24 1991-10-24 Kabi Pharmacia Ab New drug formulation
GB2360894B (en) * 2000-03-30 2004-11-10 Peter Thomas Bosson Display device support system
US8313770B2 (en) * 2007-05-30 2012-11-20 Neos Therapeutics, Lp Modifying drug release in suspensions of ionic resin systems
US20150056288A1 (en) 2011-12-14 2015-02-26 Wockhardt Limited Modified release liquid pharmaceutical composition comprising bromopheniramine, pseudoephedrine and dextromethorphan

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US3138525A (en) * 1961-06-16 1964-06-23 Hoffmann La Roche Castor wax-amprotropine-resin compositions
FR5227M (ja) * 1966-03-18 1967-08-14
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations

Also Published As

Publication number Publication date
KR850002399A (ko) 1985-05-13
EP0139881B1 (en) 1989-05-10
NZ208155A (en) 1987-09-30
IL71886A (en) 1987-11-30
JPH0688901B2 (ja) 1994-11-09
IE57445B1 (en) 1992-09-09
PH20237A (en) 1986-11-10
DK164019C (da) 1992-09-28
AU2789184A (en) 1985-03-21
FI843609L (fi) 1985-03-17
DK164019B (da) 1992-05-04
ATE42894T1 (de) 1989-05-15
DK434784A (da) 1985-03-17
JPS6067418A (ja) 1985-04-17
IL71886A0 (en) 1984-09-30
KR910003557B1 (ko) 1991-06-05
AU565487B2 (en) 1987-09-17
DK434784D0 (da) 1984-09-12
CA1221632A (en) 1987-05-12
EP0139881A1 (en) 1985-05-08
NO843673L (no) 1985-03-18
IE841201L (en) 1985-03-16
MX171030B (es) 1993-09-27
FI843609A0 (fi) 1984-09-14
DE3478085D1 (en) 1989-06-15

Similar Documents

Publication Publication Date Title
AU4936890A (en) Medicament containing dihydrolipoic acid as active substance
AU635021B2 (en) Extended release pharmaceutical formulations
DE3173434D1 (en) Trisubstituted imidazole derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use
NZ198106A (en) Pharmaceutical powder containing microencapsulated bacampicillin acid addition salt
EP0326618A4 (en) MEDICAL COMPOSITION, WHICH CONTAINS ALBUMIN AS A CARRIER, AND METHOD FOR THE PRODUCTION THEREOF.
FR2523443B1 (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
AU6770490A (en) Solid pharmaceutical compositions containing cimetidine
AU589678B2 (en) Gelatine capsules and process for their manufacture
IL67572A (en) Trans-2-aza bicyclo(3.(3+n).o)alkane-3-carboxylic acid derivatives,processes for their preparation and pharmaceutical compositions containing them
CA2033725A1 (en) Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
DE2963061D1 (en) Hydantoin compounds, their preparation and pharmaceutical formulations containing them
GR3001185T3 (en) Stable solid pharmaceutical composition containing ibuprofen and codeine
DE3478085D1 (en) Liquid prolonged release pharmaceutical formulations containing ionic constituents
AU6821687A (en) System for delivering drug with enhanced bioacceptability
IL85139A0 (en) Polymer complexes,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0327709A3 (en) Novel platinum complex, antineoplastic agent containing the same, intermediate therefor, preparation method and use
IL86269A0 (en) Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HK80888A (en) 5(6)-(2-amino-5-thiazolyl)benzimidazole-2-carbamic acid esters and their salts,their preparation and use,and pharmaceutical compositions containing them
DK427388A (da) Farmaceutiske midler indeholdende trapidil samt fremgangsmaade til fremstilling heraf
PT76951B (en) Process for the preparation of racemic or optically active eburnane-oxime derivatives and pharmaceutical compositions containing them
IL68205A (en) 5-(2-pyridylethenyl)-1h,7h-pyrazolo(1,5-a)pyrimidin-7-ones,their preparation and pharmaceutical compositions containing them
ES8505343A1 (es) Procedimiento para preparar derivados de dibenzo
TH2148EX (th) สูตรผสมยาน้ำประเภทที่ปล่อยยาเนิ่นนาน ซึ่งมีส่วนผสมชนิดไอออนิคอยู่ด้วย
IL64456A0 (en) Penicillins and salts thereof,their preparation and pharmaceutical compositions containing them
PH16897A (en) 1,3-thiazolidine-4-yl-carboxylic acid derivatives of penicillanic acid and pharmaceutical compositions containing the same